# Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients With Aneurysmal Subarachnoid Hemorrhage (HOMA)

Study · id `cardio:ct-nct05282836` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05282836](<https://clinicaltrials.gov/study/NCT05282836>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05282836

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 206 participants.

## Technical summary

Registry record NCT05282836. Randomized; single masking; primary purpose treatment. Start 2022-03-15 (anticipated); primary completion 2023-03-15 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 206 participants (planned count; ClinicalTrials.gov record NCT05282836, source copy `cardio:ctgov-nct05282836-2022-03-16`, retrieved 2026-10-31)
- Planned start: 2022-03-15 (anticipated) (ClinicalTrials.gov record NCT05282836, source copy `cardio:ctgov-nct05282836-2022-03-16`, retrieved 2026-10-31)
- Primary completion: 2023-03-15 (anticipated) (ClinicalTrials.gov record NCT05282836, source copy `cardio:ctgov-nct05282836-2022-03-16`, retrieved 2026-10-31)
- Completion: 2024-03-15 (anticipated) (ClinicalTrials.gov record NCT05282836, source copy `cardio:ctgov-nct05282836-2022-03-16`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05282836-2022-03-16`, retrieved 2026-10-31)

## The registry's words

- Brief title: Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients With Aneurysmal Subarachnoid Hemorrhage (HOMA)
- Acronym: HOMA
- Condition: Aneurysmal Subarachnoid Hemorrhage
- Intervention (Device): Hydrogen Oxygen Generator with Nebulizer
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Subarachnoid hemorrhage (`cardio:subarachnoid-hemorrhage`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

## Provenance

Content hash: 50496a222cc3f2a2df014c0bff412d154f1e1b7654b082a04213b4ef12255a62
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
